1-20 of 303
Shaji K Kumar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas

Clinical Trials & Observations
Udit Yadav, Shaji K. Kumar, Linda B. Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K. Buadi, David Dingli, Martha Q. Lacy, Rafael Fonseca, P. Leif Bergsagel, Sikander Ailawadhi, Vivek Roy, Ricardo Parrondo, Taimur Sher, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Joselle Cook, Moritz Binder, Eli Muchtar, Rahma Warsame, Taxiarchis V. Kourelis, Ronald S. Go, Yi Lin, Abhishek Seth, Scott C. Lester, William G. Breen, Robert A. Kyle, Morie A. Gertz, S. Vincent Rajkumar, Wilson I. Gonsalves
Journal: Blood
Blood (2023) 142 (22): 1871–1878.
https://doi.org/10.1182/blood.2023021187
Published: 2023
Includes: Supplemental data
Journal Articles

Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study

Shaji K Kumar, Philippe Moreau, Nizar Jacques Bahlis, Thierry Facon, Torben Plesner, Robert Z. Orlowski, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O'Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Noopur Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Huiling Pei, Maria Krevvata, Robin Carson, Fredrik Borgsten, Saad Usmani
Journal: Blood
Blood (2022) 140 (Supplement 1): 10150–10153.
https://doi.org/10.1182/blood-2022-163335
Published: 2022
Journal Articles

MonumenTAL-5: A Phase 3 Study of Talquetamab Versus Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Who Received ≥4 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and an Anti-CD38 Monoclonal Antibody

Shaji K Kumar, Alfred L. Garfall, Suzanne Trudel, Enrique M. Ocio, Emma Scott, Lin Huang, Xuewen Ma, Yunsi Olyslager, Payal Thakkar, Lixia Pei, Christoph Heuck, Evangelos Terpos
Journal: Blood
Blood (2022) 140 (Supplement 1): 7292–7293.
https://doi.org/10.1182/blood-2022-163260
Published: 2022
Journal Articles

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Biomarker-Selected Patients with Relapsed or Refractory Multiple Myeloma: Implication for Dose Selection

Mohamed A Badawi, Sheryl Coppola, Doerthe Eckert, Sathej Gopalakrishnan, Eva Doelger, Edyta Dobkowska, Shaji K Kumar, Weize Huang, Rajeev Menon, Ahmed Hamed Salem
Journal: Blood
Blood (2022) 140 (Supplement 1): 4281–4282.
https://doi.org/10.1182/blood-2022-166584
Published: 2022
Journal Articles

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma

Radhika Bansal, Sikander Ailawadhi, Jeremy T. Larsen, Morie A Gertz, Matthew A. Hathcock, David Dingli, Prashant Kapoor, Taxiarchis Kourelis, Suzanne R. Hayman, Rahma M Warsame, Moritz Binder, Ricardo D Parrondo, Rafael Fonseca, P. Leif Bergsagel, Shaji K Kumar, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 1862–1864.
https://doi.org/10.1182/blood-2022-166662
Published: 2022
Journal Articles

Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax

David Sharon, Fengjiao Dunbar, Paul Jung, Xifeng Wang, Xiaotong Li, Christine Mantis, Orlando F. Bueno, Cyrille Touzeau, Philippe Moreau, Simon J Harrison, Luciano J. Costa, Jonathan L. Kaufman, Nizar J. Bahlis, Shaji K Kumar, Jeremy A. Ross, P.K. Epling-Burnette
Journal: Blood
Blood (2022) 140 (Supplement 1): 4242–4244.
https://doi.org/10.1182/blood-2022-160195
Published: 2022
Journal Articles

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Radhika Bansal, Jonas Paludo, Matthew A. Hathcock, Megan T Spychalla, Arushi Khurana, Paul J. Hampel, Urshila Durani, Hassan B. Alkhateeb, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Yucai Wang, Saad S. Kenderian, Moritz Binder, Taxiarchis Kourelis, Shaji K Kumar, Mithun V. Shah, Rahma M Warsame, N. Nora Bennani, Morie A Gertz, Patrick B. Johnston, Stephen M. Ansell, Mustaqeem A. Siddiqui, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 2399–2401.
https://doi.org/10.1182/blood-2022-167187
Published: 2022
Journal Articles

Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome

Karan Chohan, Saurabh Zanwar, Ronald Go, Jonas Paludo, Carrie A. Thompson, Asher Chanan-Khan, Sikander Ailawadhi, Thomas M. Habermann, Thomas E. Witzig, Morie A Gertz, Stephen M. Ansell, Shaji K Kumar, Rajiv K. Pruthi, William L. Nichols, Prashant Kapoor, Meera Sridharan, Jithma P. Abeykoon
Journal: Blood
Blood (2022) 140 (Supplement 1): 9363–9365.
https://doi.org/10.1182/blood-2022-168232
Published: 2022
Journal Articles

Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma

Walker M Schmidt, Francis K. Buadi, Suzanne R. Hayman, Shaji K Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q. Lacy, Prashant Kapoor, Nelson Leung, Eli Muchtar, Rahma M Warsame, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, Morie A. Gertz
Journal: Blood
Blood (2022) 140 (Supplement 1): 7182–7184.
https://doi.org/10.1182/blood-2022-156078
Published: 2022
Journal Articles

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Cecilia Bonolo De Campos, James B Smadbeck, Mariano Arribas, Neeraj Sharma, Gregory J Ahmann, Shaji K Kumar, A. Keith Stewart, Rafael Fonseca, P. Leif Bergsagel, Yan Asmann, Linda B. Baughn, Esteban Braggio
Journal: Blood
Blood (2022) 140 (Supplement 1): 7180–7181.
https://doi.org/10.1182/blood-2022-170749
Published: 2022
Journal Articles

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy T. Larsen, P. Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Wilson I. Gonsalves, Ronald Go, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma M Warsame, Amie Fonder, Miriam A. Hobbs, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10017–10019.
https://doi.org/10.1182/blood-2022-167181
Published: 2022
Journal Articles

Immunoglobulin Heavy Chain Amyloidosis: Patient Characteristics and Outcomes

Mohammad S Ebraheem, Eli Muchtar, Shaji K Kumar, Angela Dispenzieri, Francis K. Buadi, David Dingli, Joselle Cook, Martha Q. Lacy, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Rahma M Warsame, Taxiarchis Kourelis, Moritz Binder, Ronald Go, Amie Fonder, Yi L. Hwa, Miriam A. Hobbs, Wilson I. Gonsalves, S. Vincent Rajkumar, Robert A. Kyle, Morie A Gertz
Journal: Blood
Blood (2022) 140 (Supplement 1): 8092–8093.
https://doi.org/10.1182/blood-2022-164617
Published: 2022
Journal Articles

Muscle and Fat Composition in Patients with Newly Diagnosed Multiple Myeloma

Nadine Abdallah, Hiroki Nagayama, Naoki Takahashi, Wilson I. Gonsalves, Amie Fonder, Angela Dispenzieri, David Dingli, Francis K. Buadi, Martha Q. Lacy, Miriam A. Hobbs, Morie A. Gertz, Moritz Binder, Prashant Kapoor, Rahma M Warsame, Suzanne R. Hayman, Taxiarchis Kourelis, Yi L. Hwa, Yi Lin, Robert A. Kyle, S. Vincent Rajkumar, Stephen Broski, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 7141–7143.
https://doi.org/10.1182/blood-2022-163746
Published: 2022
Journal Articles

Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib

Reyka G. Jayasinghe, George Mulligan, April Cook, Mark Hamilton, Sacha Gnjatic, Seunghee Kim-Schulze, Hearn J. Cho, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 7090–7091.
https://doi.org/10.1182/blood-2022-167462
Published: 2022
Journal Articles

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Jason N Barreto, Erin F Barreto, Kristin C. Mara, Andrew D. Rule, Marissa Z. Powell, Radhika Bansal, Matthew A. Hathcock, Sandra M. Herrmann, Adrienne N. Nedved, Stephen M. Ansell, N. Nora Bennani, Jonas Paludo, Patrick B. Johnston, Urshila Durani, Tyler B. Sandahl, Yucai Wang, Arushi Khurana, Hassan B. Alkhateeb, Mithun V. Shah, Prashant Kapoor, Morie A Gertz, Shaji K Kumar, David Dingli, Taxiarchis Kourelis, Rahma M Warsame, Suzanne R. Hayman, Nelson Leung, Yi Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 10942–10944.
https://doi.org/10.1182/blood-2022-164785
Published: 2022
Journal Articles

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Andrea Angioi, Moritz Binder, Nelson Leung, Frank Bridoux, Camille Cohen, David Dingli, Angela Dispenzieri, Parikshit Duriseti, Roberta Fenoglio, Amie Fonder, Morie A. Gertz, Ronald Go, Wilson I. Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Prashant Kapoor, Bertrand Knebelmann, Taxiarchis Kourelis, Shaji K Kumar, Robert A. Kyle, Martha Q. Lacy, Nicola Lepori, Yi Lin, Shveta Motwani, Eli Muchtar, Samih Nasr, Antonello Pani, Dario Roccatello, Virginie Royal, Paul Sanders, Stephan Troyanov, Christopher P. Venner, Rahma M Warsame, Niloufarsadat Yarandi, S. Vincent Rajkumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10068–10070.
https://doi.org/10.1182/blood-2022-162754
Published: 2022
Journal Articles

Optimal Sequencing Determination in Relapsed Multiple Myeloma

Salyka M. Sengsayadeth, Bridget Fitzgerald, Bharat Nandakumar, Bicky Thapa, Timothy Martin Schmidt, Rebecca Silbermann, Heidi Chen, Saurabh Chhabra, Natalie Callander, Shaji K Kumar, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 10033–10035.
https://doi.org/10.1182/blood-2022-169589
Published: 2022
Journal Articles

A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Wilson I. Gonsalves, Natalia Neparidze, Jacob B. Allred, Shaji K Kumar, Joel M. Reid, Geoffrey Shapiro, Brian A. Costello, Richard Piekarz, Rachid C. Baz, Srinivas Devarakonda
Journal: Blood
Blood (2022) 140 (Supplement 1): 7315–7316.
https://doi.org/10.1182/blood-2022-164966
Published: 2022
Journal Articles

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, Peiyu Yang, Haimin Chen, Xinyue Liang, Weiling Xu, Shanshan Yu, Wenyang Huang, Xingchen Yi, Qiang Guo, Mengru Tian, Tingting Yue, Mengyao Li, Yingjie Zhang, Mengxue Zhang, Yurong Yan, Zhongli Hu, Shaji K Kumar, Fan Zhou, Yun Dai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4360–4361.
https://doi.org/10.1182/blood-2022-168602
Published: 2022
Journal Articles

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes

Shaji K Kumar, Betsy Laplant, Erik J Asmus, Francis K. Buadi, Wilson I. Gonsalves, Eli Muchtar, David Dingli, Melanie Ann Thompson, Ronald Go, Rahma M Warsame, Taxiarchis Kourelis, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Martha Q. Lacy, Angela Dispenzieri, Suzanne R. Hayman, Nelson Leung, Moritz Binder, S. Vincent Rajkumar, Morie A Gertz, Prashant Kapoor
Journal: Blood
Blood (2022) 140 (Supplement 1): 10142–10143.
https://doi.org/10.1182/blood-2022-169046
Published: 2022